You are here

microbiome

Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline

Finch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline

Xconomy

Finch Therapeutics

Seres Therapeutics

Flag link:

Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win

Battered and bruised Seres Therapeutics see shares skyrocket on phase 3 win

Fierce Biotech

Seres Therapeutics

Flag link:

Seres Therapeutics stock rockets nearly fourfold after positive Phase 3 data on treatment for colon infections

Seres Therapeutics stock rockets nearly fourfold after positive Phase 3 data on treatment for colon infections

Marketwatch

Seres Therapeutics

clinical trials

Flag link:

Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work

Takeda joins microbiome-focused biotech partner's $52.6M raise as it pursues more in-house cancer work

Endpoints

Flag link:

Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact

Amid Allergan buyout, AbbVie dumps unwanted Assembly microbiome pact

Fierce Biotech

Assembly Biosciences

Flag link:

In big year for microbiome drugs, a small biotech sets the bar

In big year for microbiome drugs, a small biotech sets the bar

BioPharma Dive

Finch Therapeutics

Flag link:

Ferring’s gut microbiome drug clears phase 3 trial in C. diff

Ferring’s gut microbiome drug clears phase 3 trial in C. diff

Pharmaforum

Ferring Pharmaceuticals

clinical trials

Flag link:

Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study

Heart Drugs May Influence Gut Microbiome In Obese People, Says New Study

Forbes

Flag link:

Gilead to lean on Second Genome's microbiome work in $38M research pact

Gilead to lean on Second Genome's microbiome work in $38M research pact

BioPharma Dive

Gilead Sciences

Flag link:

Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic

Kintai’s obesity drug that works via the gut microbiome moves closer to the clinic

Fierce Biotech

Kintai Therapeutics

Flag link:

Gut link to Parkinson's sparks talk of probiotic treatment strategy

Gut link to Parkinson's sparks talk of probiotic treatment strategy

Fierce Biotech

Parkinson's Disease

Flag link:

Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy

Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy

Xconomy

Novome Biotechnologies

Flag link:

Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs

Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs

Endpoints

Flag link:

Treating multiple sclerosis with the help of the gut microbiome

Treating multiple sclerosis with the help of the gut microbiome

Fierce Biotech

Brigham and Women's

multiple sclerosis

Flag link:

Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease

Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease

Endpoints

Finch Therapeutics

Crohn's Disease

Flag link:

France's Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate

France's Enterome Teams Up with Cancer Center to Validate Immunotherapy Candidate

BioSpace

Memorial Sloan Kettering

cancer immunotherapy

Flag link:

Thermo Fisher hooks gut onto its gene therapy pipeline, inks new collaboration pact

Thermo Fisher hooks gut onto its gene therapy pipeline, inks new collaboration pact

Endpoints

Flag link:

Microbiome Report

Microbiome Report

CP Wire

LNC Therapeutics

Flag link:

Microbiome Report

LNC Therapeutics

Flag link:

Troubled poop-testing startup uBiome announces plans for liquidation

Troubled poop-testing startup uBiome announces plans for liquidation

Endpoints

Flag link:

Pages